Storing and administering a peptide nasal spray is easy and convenient, and there is ample evidence to support the effectiveness of intranasal administration of peptides
It is recommended to follow the storage instructions carefully to ensure the efficacy and safety of the medication
Faseb J 14(15):24508
b , Quantification of the intestinal nuclei based on their morphology as depicted in ( a )
Key Dates Include: Pre-release: December 4, 2024 Open for proposal submissions: January 8, 2025 DSIP Topic Q&A Closure: January 22, 2025, at 10:00 AM MT Close for proposal submissions: February 5, 2025, at 10:00 AM MT Participating DoD Components: Department of the Navy (Navy) Department of the Air Force (Air Force) Defense Health Agency (DHA) Missile Defense Agency (MDA) For further details on active topics and the submission process, you can explore the DoDs SBIR/STTR portal here
Summary: This phase 3a, 68-week, double-blind, placebo-controlled trial investigated the efficacy and safety of coadministering Cagrilintide and Semaglutide